Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

1.73
Delayed Data
As of 3:59pm ET
 -0.01 / -0.57%
Today’s Change
1.71
Today|||52-Week Range
7.22
-54.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-56.6M-66.4M-39.5M-55.5M
 
 
 
 
 
Depreciation9.0M1.6M1.6M2.2M
 
 
 
 
 
Total Other Cash Flow32.1M48.1M8.2M8.2M
 
 
 
 
 
Funds From Operations-16.2M-16.9M-28.9M-45.2M
 
 
 
 
 
Funds From/For Other Operating Expenses4.7M-3.1M-1.8M1.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-20.9M-13.9M-27.1M-46.9M
 
 
 
 
 
 
InvestingIncrease In Investments-28.000.000.00-8.0M
 
 
 
Decrease In Investments0.000.000.00913.0K
 
 
Capital Expenditures-5.9M-531.3K-2.7M-3.7M
 
 
 
 
 
Fixed Asset Disposal320.9K----50.9K
 
 
 
Other Investing - Uses0.00-5.7M0.000.00
 
 
Other Investing - Sources3.5M12.3M0.000.00
 
 
 
Net Cash Flow Investing-2.1M6.1M-2.7M-10.7M
 
 
 
 
 
 
FinancingShort Term Borrowings2.4M-196.6K-201.8K-3.2M
 
 
 
 
 
Long Term Borrowings0.00666.5K1.0M16.3M
 
 
 
 
Long Term Debt Reduction0.00-440.5K-503.2K-1.1M
 
 
 
 
Net Proceeds Stock Sale21.2M23.0M61.9M18.7M
 
 
 
 
 
Common Preferred Redeemed0.00-5.4M0.000.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.00-327.7K0.000.00
 
 
Other Sources - Financing644.4K0.000.000.00
 
 
Other Uses - Financing4.2M8.6M62.0K0.00
 
 
 
 
Net Cash Flow - Financing20.1M8.7M62.2M30.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash46.2K14.4K0.000.00
 
 
 
 
Net Change In Cash-2.9M977.6K32.4M-27.0M